As previously announced, Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, is seeking ...
Eclipse Bioinnovations, Inc. (Eclipsebio), the leader in sequencing-based analytics and AI-enabled design for RNA therapeutics, today announced the launch of its eCOMPASStm lab-in-the-loop platform, ...
RECIST-based ORR of 61.5% with a complete response (CR) rate of 23% – No Grade 3 or higher adverse events related to RZ-001 observed – Highlights clinical potential of RNA trans-splicing ribozyme ...
If forced to choose one descriptor for the octopus, the best word may be “otherworldly.” These truly amazing marine animals ...
Drug development is aiming to move from managing disease to correcting it through RNA and gene-editing therapies. But ...
But delivering these treatments safely and precisely to the right cells remains a major hurdle—especially in hard-to-target organs like the brain and kidneys. Now, researchers led by a University of ...
Morning Overview on MSN
New CRISPR variant cuts tumor DNA while sparing healthy cells
Most gene-editing tools are blind to context. Point them at a DNA sequence and they cut, whether that sequence sits inside a ...
Researchers at the MRC Laboratory of Medical Sciences (LMS) and Imperial College London have identified an overworked cog in ...
Lisa Taylor Ash joins Board of Directors, strengthening operational, regulatory and commercial expertise DUBLIN and LONDON, ...
Scientists have gained tremendous control over the genome with CRISPR editing systems, that use a guide RNA molecule to ...
ProQR Therapeutics is a high-potential, early-stage RNA editing platform company, but remains pre-proof-of-mechanism in ...
Now, following up on that success, a large Chinese collaboration has followed up with a description of an improved gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results